Jane Street’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Buy |
+10,533
| New | +$30.4K | ﹤0.01% | 5162 |
|
|
2025
Q1 | – | Sell |
-33,781
| Closed | -$131K | – | 6166 |
|
|
2024
Q4 | $131K | Sell |
33,781
-80,002
| -70% | -$310K | ﹤0.01% | 5253 |
|
|
2024
Q3 | $745K | Buy |
113,783
+50,622
| +80% | +$332K | ﹤0.01% | 3811 |
|
|
2024
Q2 | $458K | Buy |
63,161
+24,336
| +63% | +$176K | ﹤0.01% | 4616 |
|
|
2024
Q1 | $295K | Buy |
+38,825
| New | +$295K | ﹤0.01% | 4650 |
|
|
2023
Q3 | – | Sell |
-19,565
| Closed | -$61.2K | – | 5465 |
|
|
2023
Q2 | $61.2K | Sell |
19,565
-122,017
| -86% | -$382K | ﹤0.01% | 4917 |
|
|
2023
Q1 | $641K | Buy |
141,582
+113,627
| +406% | +$515K | ﹤0.01% | 3390 |
|
|
2022
Q4 | $115K | Buy |
+27,955
| New | +$115K | ﹤0.01% | 4638 |
|
|
2021
Q4 | – | Sell |
-12,001
| Closed | -$138K | – | 5687 |
|
|
2021
Q3 | $138K | Buy |
+12,001
| New | +$138K | ﹤0.01% | 4575 |
|
|
2020
Q1 | – | Sell |
-4,999
| Closed | -$67K | – | 3739 |
|
|
2019
Q4 | $67K | Buy |
+4,999
| New | +$67K | ﹤0.01% | 3129 |
|
|
2019
Q3 | – | Sell |
-9,305
| Closed | -$133K | – | 3763 |
|
|
2019
Q2 | $133K | Buy |
+9,305
| New | +$133K | ﹤0.01% | 3219 |
|
|
2019
Q1 | – | Sell |
-1,667
| Closed | -$99K | – | 3547 |
|
|
2018
Q4 | $99K | Buy |
+1,667
| New | +$99K | ﹤0.01% | 2951 |
|
|
2016
Q2 | – | Sell |
-1,273
| Closed | -$102K | – | 2804 |
|
|
2016
Q1 | $102K | Buy |
+1,273
| New | +$102K | ﹤0.01% | 2416 |
|